Literature DB >> 25070151

Immunofluorescence mapping in inherited epidermolysis bullosa: a study of 86 cases from India.

R Hiremagalore1, A Kubba, S Bansel, H Jerajani.   

Abstract

BACKGROUND: Epidermolysis bullosa (EB) poses diagnostic challenges in infancy. In India, the diagnosis is largely clinical. There were no facilities to perform immunofluorescence mapping (IFM) until recently, and electron microscopy, which requires expertise to interpret, is limited to a few research laboratories.
OBJECTIVES: To describe the patterns of IFM staining in the various forms of EB in Indian patients and to correlate these findings with clinical diagnosis.
METHODS: We conducted a cross-sectional study of IFM findings in EB. Antibodies against type IV collagen, cytokeratin 14, laminin 332 and type VII collagen were used. Clinical correlation was performed in all cases, and concordance-discordance rates were calculated.
RESULTS: Eighty-six patients with a diagnosis of EB were included in the study. There were 29 with EB simplex (EBS), 18 with junctional EB (JEB) and 15 with dystrophic EB (DEB). The remaining 24 cases included rare variants, cases with overlapping clinical features and cases where the type of EB was not known. On IFM diagnosis, there were 32 cases of EBS, 15 JEB, 17 DEB and two Kindler syndrome. Two cases were not EB and 18 were inconclusive. IFM could establish the type in 12 of 15 cases (80%) that had overlapping clinical features. Most of these cases were under 1 year of age. Overall the concordance was 57% and was seen best in cases of EBS.
CONCLUSIONS: This is the first large study of IFM of the subtypes of EB in Indian patients. The study provides a framework for better understanding of EB in Indian patients and for better diagnosis and management, particularly in infancy.
© 2014 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25070151     DOI: 10.1111/bjd.13305

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  Case Report: Whole exome sequencing reveals a novel frameshift deletion mutation p.G2254fs in COL7A1 associated with autosomal recessive dystrophic epidermolysis bullosa.

Authors:  Shamsudheen Karuthedath Vellarikkal; Rijith Jayarajan; Ankit Verma; Sreelata Nair; Rowmika Ravi; Vigneshwar Senthivel; Sridhar Sivasubbu; Vinod Scaria
Journal:  F1000Res       Date:  2016-05-17

2.  A novel KRT5 mutation associated with generalized severe epidermolysis bullosa simplex in a 2-year-old Chinese boy.

Authors:  Jia Zhang; Ming Yan; Jianying Liang; Ming Li; Zhirong Yao
Journal:  Exp Ther Med       Date:  2016-09-20       Impact factor: 2.447

3.  Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa.

Authors:  C Has; L Liu; M C Bolling; A V Charlesworth; M El Hachem; M J Escámez; I Fuentes; S Büchel; R Hiremagalore; G Pohla-Gubo; P C van den Akker; K Wertheim-Tysarowska; G Zambruno
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

4.  Known and novel mutations responsible for epidermolysis bullosa simplex cases in a Chinese population.

Authors:  Jia Zhang; Yu Ding; Ming Li; Zhirong Yao; Yin Zhuang
Journal:  Exp Ther Med       Date:  2019-10-25       Impact factor: 2.447

5.  Utility of Immunofluorescence Antigen Mapping in Hereditary Epidermolysis Bullosa.

Authors:  Raghavendra Rao; Varsha M Shetty
Journal:  Indian J Dermatol       Date:  2021 Jul-Aug       Impact factor: 1.494

6.  Lysyl Hydroxylase 3 Localizes to Epidermal Basement Membrane and Is Reduced in Patients with Recessive Dystrophic Epidermolysis Bullosa.

Authors:  Stephen A Watt; Jasbani H S Dayal; Sheila Wright; Megan Riddle; Celine Pourreyron; James R McMillan; Roy M Kimble; Marco Prisco; Ulrike Gartner; Emma Warbrick; W H Irwin McLean; Irene M Leigh; John A McGrath; Julio C Salas-Alanis; Jakub Tolar; Andrew P South
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.